Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cultural Adaptation of Sedentary Behavior Questionnaire and Reliability, Validity Research of Turkish Version

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03586349
Recruitment Status : Completed
First Posted : July 13, 2018
Last Update Posted : January 16, 2019
Sponsor:
Collaborator:
Istanbul University
Information provided by (Responsible Party):
Begum Kara Kaya, Biruni University

Brief Summary:
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. The permission was obtained via mail from Dori Rosenberg, who is the developer of the questionnaire, for its Turkish adaptation. SPSS package programme will be used in the analysis,

Condition or disease
Healthy Adults

Detailed Description:
The aim of this study is to adapt the Sedentary Behavior Questionnaire (SBQ) into the culture of Turkish and to work on the reliability and validity of it in healthy individuals between the ages of 18-64. Original form has nine questions but Spanish version of it had eleven questions so the investigators will translate Spanish version of SBQ. At first step by using a forward-backward translation method, a translation and adaptation process will be performed. At second step the validation process will be performed in a total of 200 healthy subjects aged between 18-64 years. Subjects will fill sociodemographic information form, International Physical Activity Questionnaire Short Form, and SBQ Turkish version ( at baseline and after seven days). Cronbach's alpha values, confirmatory factor analysis (CFA) will be evaluated for the reliability, construct and convergent validity.

Layout table for study information
Study Type : Observational
Actual Enrollment : 210 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Cultural Adaptation of Sedentary Behavior Questionnaire and Reliability, Validity Research of Turkish Version
Actual Study Start Date : January 1, 2018
Actual Primary Completion Date : July 1, 2018
Actual Study Completion Date : September 30, 2018

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Sedentary Behavior Questionnaire [ Time Frame: 1 week ]
    Sedentary Behavior Questionnaire scales the amount of time spent doing 11 sedentary behaviors.Response options are none, 15 minutes or less, 30 minutes, 1 hour, 2 hours,3 hours, 4 hours, 5 hours, 6 hours or more. In the scoring the time spent on each behavior is converted into hours (eg, a response of 15 minutes is recoded as .25 hours). For the total scores of sedentary behavior, responsed hours per day for each behavior are summed separately for weekday and weekend days. For the summary scores of total hours/day spent in sedentary behaviors (weekday and weekend) and total sedentary hours/week, responses higher than 24 hours/day are truncated to 24 hours/day. There are not any normative variables of Sedentary Behavior Questionnaire.


Secondary Outcome Measures :
  1. International Physical Activity Questionnaire Short Form [ Time Frame: Day 1 ]
    International Physical Activity Questionnaire Short Form(IPAQ-SF) scales the types of intensity of physical activity and sitting time that people do as part of their daily lives. The short form records the physical activity of 3 different intensity levels: 1) vigorous-intensity activity such as aerobics (8.0 MET), 2) moderate-intensity activity such as leisure cycling (4.0 MET), 3) walking (3.3 MET). The IPAQ-SF questions activities for last 7 days with 7 items. In the scoring total estimate physical activity in MET-min/week and time spent while sitting are calculated ( Ex. 4.0 METx activity dayx activity duration (in minutes) equals moderate-intensity activity total MET score).According to scores subjects are categorized as inactive (achieving <600 MET-min/week), minimally active (achieving a minimum of at least 600 MET-min/week and <3000 MET-min/week), active (>3000 MET-min/week).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy adults aged between 18-64 years.
Criteria

Inclusion Criteria:

  • Being a healthy individual between the ages of 18-64.
  • No problem of reading, writing or understanding Turkish.

Exclusion Criteria:

  • Severe trauma in the last 6 months.
  • Having orthopedic, neurological, cardiovascular problems that restricts ambulation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03586349


Locations
Layout table for location information
Turkey
Biruni University
Istanbul, Turkey
Sponsors and Collaborators
Begum Kara Kaya
Istanbul University
Investigators
Layout table for investigator information
Principal Investigator: Ayse Zengin Alpozgen Istanbul University

Layout table for additonal information
Responsible Party: Begum Kara Kaya, Lecturer, Biruni University
ClinicalTrials.gov Identifier: NCT03586349     History of Changes
Other Study ID Numbers: Study
First Posted: July 13, 2018    Key Record Dates
Last Update Posted: January 16, 2019
Last Verified: July 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No